These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6215927)

  • 1. [Vigilance behavior in interaction of the serotonin-selective antidepressant zimelidine and parenterally administered ethanol].
    Schaffler K; Arnold H; Hörmann E
    Arzneimittelforschung; 1982; 32(8):845-52. PubMed ID: 6215927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables.
    Schenk GK; Filler W; Ranft W; Zerbin D
    Acta Psychiatr Scand Suppl; 1981; 290():303-13. PubMed ID: 6452797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amitriptyline and zimelidine in combination with ethanol.
    Scott DB; Fagan D; Tiplady B
    Psychopharmacology (Berl); 1982; 76(3):209-11. PubMed ID: 6212962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
    Wilkinson CJ
    J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of voluntary morphine consumption following treatment with zimelidine.
    Rockman GE; Amit Z; Bourque C; Brown ZW; Ogren SO
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):123-9. PubMed ID: 6448029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zimelidine, a new antidepressant, on appetite and body weight.
    Simpson RJ; Lawton DJ; Watt MH; Tiplady B
    Br J Clin Pharmacol; 1981 Jan; 11(1):96-8. PubMed ID: 6452151
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients.
    Johansson F; von Knorring L; Sedvall G; Terenius L
    Psychiatry Res; 1980 May; 2(2):167-72. PubMed ID: 6158065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites.
    Lundström J; Högberg T; Gosztonyi T; de Paulis T
    Arzneimittelforschung; 1981; 31(3):486-94. PubMed ID: 6452883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.
    Potter WZ; Calil HM; Extein I; Zavadil AP; Goodwin FK
    Psychiatry Res; 1979 Dec; 1(3):273-81. PubMed ID: 298355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake.
    Gebhart GF; Lorens SA
    Br J Pharmacol; 1980 Nov; 70(3):411-4. PubMed ID: 6449224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative changes in saliva composition after short-term administration of imipramine and zimelidine in healthy volunteers.
    von Knorring L; Mörnstad H
    Scand J Dent Res; 1981 Aug; 89(4):313-20. PubMed ID: 6458872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of zimelidine on various transmitter systems in the brain.
    Hall H; Ross SB; Ogren SO
    Adv Biochem Psychopharmacol; 1982; 31():321-5. PubMed ID: 6282061
    [No Abstract]   [Full Text] [Related]  

  • 16. Saccadic eye movements are associated with a family history of alcoholism at baseline and after exposure to alcohol.
    Blekher T; Ramchandani VA; Flury L; Foroud T; Kareken D; Yee RD; Li TK; O'Connor S
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1568-73. PubMed ID: 12394291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical effects of zimelidine in man.
    Bertilsson L; Tuck JR; Siwers B
    Eur J Clin Pharmacol; 1980 Nov; 18(6):483-7. PubMed ID: 6450684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of zimelidine and other antidepressant in conscious rats.
    Lindbom LO; Forsberg T
    Acta Psychiatr Scand Suppl; 1981; 290():380-4. PubMed ID: 6452801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute doses of zimelidine on REM sleep in rats.
    Reyes RB; Hill SY; Kupfer DJ
    Psychopharmacology (Berl); 1983; 80(3):214-6. PubMed ID: 6225137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.